An open-label study of sodium oxybate in Spasmodic dysphonia.

about

Central voice production and pathophysiology of spasmodic dysphonia.Phenomenology, genetics, and CNS network abnormalities in laryngeal dystonia: A 30-year experience.The direct basal ganglia pathway is hyperfunctional in focal dystonia.

P2860

Q38679156-55021632-737A-46DB-85AC-DC06860683A2 Q46539946-93DB0F03-B3DF-4854-BC1E-8F7C5F147FEB Q47993666-9774CC50-4977-48E3-A9E8-683913F69C2F

P2860

An open-label study of sodium oxybate in Spasmodic dysphonia.

Item

http://www.wikidata.org/entity/Q47369477

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

An open-label study of sodium oxybate in Spasmodic dysphonia.

@en

An open-label study of sodium oxybate in Spasmodic dysphonia.

@nl

type

Item

label

An open-label study of sodium oxybate in Spasmodic dysphonia.

@en

An open-label study of sodium oxybate in Spasmodic dysphonia.

@nl

prefLabel

An open-label study of sodium oxybate in Spasmodic dysphonia.

@en

An open-label study of sodium oxybate in Spasmodic dysphonia.

@nl

P1476

An open-label study of sodium oxybate in Spasmodic dysphonia.

@en

P2093

Andrew Blitzer

http://www.w3.org/2001/XMLSchema#string

Kristina Simonyan

http://www.w3.org/2001/XMLSchema#string

P2860

Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion

Unravelling the brain targets of gamma-hydroxybutyric acid

A review on alcohol: from the central action mechanism to chemical dependency

A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor

Emerging concepts in the physiological basis of dystonia

Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia.

Abnormal activation of the primary somatosensory cortex in spasmodic dysphonia: an fMRI study.

Research priorities in spasmodic dysphonia

Focal white matter changes in spasmodic dysphonia: a combined diffusion tensor imaging and neuropathological study.

Mechanism of the antialcohol effect of gamma-hydroxybutyric acid.

P304

1402-1407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/LARY.26381

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P50

S Frucht

Anna F Rumbach

P577

2016-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27808415

http://www.w3.org/2001/XMLSchema#string

P932

5415435

http://www.w3.org/2001/XMLSchema#string

An open-label study of sodium oxybate in Spasmodic dysphonia.

about

P2860

P2860

An open-label study of sodium oxybate in Spasmodic dysphonia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932